APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Penicillin Intermediate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Penicillin Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174023360329 December 2025194 pages

Choose your research edition.

Industry ResearchPenicillin Intermediate Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin Intermediate Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Penicillin Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin Intermediate Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin Intermediate Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Penicillin Intermediate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Penicillin Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Penicillin Intermediate include Sinopharm Weiqida Pharmaceutical, Kasugamycin hydrochloride, Shanghai Hongsheng, Apeloa Pharmaceutical, The United Laboratories International Holdings Limited, Sichuan Kelun Pharmaceutical, Jiangxi Huabang, North China Pharmaceutical Company and Henan Huaxing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Penicillin Intermediate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Penicillin Intermediate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Penicillin Intermediate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Penicillin Intermediate market size, projected growth trends, production technologies, key applications, and end-use industries.

Penicillin Intermediate Segment by Company

Sinopharm Weiqida Pharmaceutical

Kasugamycin hydrochloride

Shanghai Hongsheng

Apeloa Pharmaceutical

The United Laboratories International Holdings Limited

Sichuan Kelun Pharmaceutical

Jiangxi Huabang

North China Pharmaceutical Company

Henan Huaxing

Harbin Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Fuan Pharmaceutical group

Yili Chuanning Biotechnology

Changzhou RedSun

Centrient Pharmaceuticals

XINXIANG BEST PHARMACEUTICAL

United Laboratories

TUL

Sinopharm Weiqida Pharmaceutical

Sichuan Huaxin

Qilu Tianhe Pharma

Novartis Sandoz Anti-Infectives

LKPC

Kelun

Jiangxi Fushine Pharmaceutical

Huayao Group

Hayao

E-Cspc

CSPC Zhongrun

Penicillin Intermediate Segment by Type

6-APA

Penicillin G and V Potassium Salt

Others

Penicillin Intermediate Segment by Application

Penicillin Antibiotics

Cephalosporin Antibiotics

Penicillin Intermediate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Penicillin Intermediate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Penicillin Intermediate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Penicillin Intermediate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Penicillin Intermediate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Penicillin Intermediate Industry Trends Table 2. Penicillin Intermediate Industry Drivers Table 3. Penicillin Intermediate Industry Opportunities and Challenges Table 4. Penicillin Intermediate Industry Restraints Table 5. Global Penicillin Intermediate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Penicillin Intermediate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Penicillin Intermediate Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Penicillin Intermediate Sales Market Share by Manufacturers Table 9. Global Penicillin Intermediate Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Penicillin Intermediate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Penicillin Intermediate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Penicillin Intermediate Manufacturers, Product Type & Application Table 13. Global Penicillin Intermediate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Penicillin Intermediate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 6-APA Table 17. Major Manufacturers of Penicillin G and V Potassium Salt Table 18. Major Manufacturers of Others Table 19. Global Penicillin Intermediate Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 21. Global Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 22. Global Penicillin Intermediate Sales Market Share by Type (2021-2026) Table 23. Global Penicillin Intermediate Sales Market Share by Type (2027-2032) Table 24. Global Penicillin Intermediate Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Penicillin Intermediate Revenue by Type (2021-2026) & (Tons) Table 26. Global Penicillin Intermediate Revenue by Type (2027-2032) & (Tons) Table 27. Global Penicillin Intermediate Revenue Market Share by Type (2021-2026) Table 28. Global Penicillin Intermediate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Penicillin Antibiotics Table 30. Major Manufacturers of Cephalosporin Antibiotics Table 31. Global Penicillin Intermediate Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 33. Global Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 34. Global Penicillin Intermediate Sales Market Share by Application (2021-2026) Table 35. Global Penicillin Intermediate Sales Market Share by Application (2027-2032) Table 36. Global Penicillin Intermediate Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Penicillin Intermediate Revenue by Application (2021-2026) & (Tons) Table 38. Global Penicillin Intermediate Revenue by Application (2027-2032) & (Tons) Table 39. Global Penicillin Intermediate Revenue Market Share by Application (2021-2026) Table 40. Global Penicillin Intermediate Revenue Market Share by Application (2027-2032) Table 41. Global Penicillin Intermediate Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Penicillin Intermediate Sales by Region (2021-2026) & (Tons) Table 43. Global Penicillin Intermediate Sales Market Share by Region (2021-2026) Table 44. Global Penicillin Intermediate Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Penicillin Intermediate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 48. North America Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 49. Europe Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 51. Europe Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 58. Global Penicillin Intermediate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Penicillin Intermediate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Penicillin Intermediate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Penicillin Intermediate Revenue Market Share by Region (2021-2026) Table 62. Global Penicillin Intermediate Revenue Market Share by Region (2027-2032) Table 63. Sinopharm Weiqida Pharmaceutical Company Information Table 64. Sinopharm Weiqida Pharmaceutical Business Overview Table 65. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 67. Sinopharm Weiqida Pharmaceutical Recent Development Table 68. Kasugamycin hydrochloride Company Information Table 69. Kasugamycin hydrochloride Business Overview Table 70. Kasugamycin hydrochloride Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio Table 72. Kasugamycin hydrochloride Recent Development Table 73. Shanghai Hongsheng Company Information Table 74. Shanghai Hongsheng Business Overview Table 75. Shanghai Hongsheng Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai Hongsheng Penicillin Intermediate Product Portfolio Table 77. Shanghai Hongsheng Recent Development Table 78. Apeloa Pharmaceutical Company Information Table 79. Apeloa Pharmaceutical Business Overview Table 80. Apeloa Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio Table 82. Apeloa Pharmaceutical Recent Development Table 83. The United Laboratories International Holdings Limited Company Information Table 84. The United Laboratories International Holdings Limited Business Overview Table 85. The United Laboratories International Holdings Limited Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio Table 87. The United Laboratories International Holdings Limited Recent Development Table 88. Sichuan Kelun Pharmaceutical Company Information Table 89. Sichuan Kelun Pharmaceutical Business Overview Table 90. Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio Table 92. Sichuan Kelun Pharmaceutical Recent Development Table 93. Jiangxi Huabang Company Information Table 94. Jiangxi Huabang Business Overview Table 95. Jiangxi Huabang Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jiangxi Huabang Penicillin Intermediate Product Portfolio Table 97. Jiangxi Huabang Recent Development Table 98. North China Pharmaceutical Company Company Information Table 99. North China Pharmaceutical Company Business Overview Table 100. North China Pharmaceutical Company Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. North China Pharmaceutical Company Penicillin Intermediate Product Portfolio Table 102. North China Pharmaceutical Company Recent Development Table 103. Henan Huaxing Company Information Table 104. Henan Huaxing Business Overview Table 105. Henan Huaxing Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Henan Huaxing Penicillin Intermediate Product Portfolio Table 107. Henan Huaxing Recent Development Table 108. Harbin Pharmaceutical Group Company Information Table 109. Harbin Pharmaceutical Group Business Overview Table 110. Harbin Pharmaceutical Group Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio Table 112. Harbin Pharmaceutical Group Recent Development Table 113. Shanghai Shyndec Pharmaceutical Company Information Table 114. Shanghai Shyndec Pharmaceutical Business Overview Table 115. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio Table 117. Shanghai Shyndec Pharmaceutical Recent Development Table 118. Fuan Pharmaceutical group Company Information Table 119. Fuan Pharmaceutical group Business Overview Table 120. Fuan Pharmaceutical group Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio Table 122. Fuan Pharmaceutical group Recent Development Table 123. Yili Chuanning Biotechnology Company Information Table 124. Yili Chuanning Biotechnology Business Overview Table 125. Yili Chuanning Biotechnology Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio Table 127. Yili Chuanning Biotechnology Recent Development Table 128. Changzhou RedSun Company Information Table 129. Changzhou RedSun Business Overview Table 130. Changzhou RedSun Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Changzhou RedSun Penicillin Intermediate Product Portfolio Table 132. Changzhou RedSun Recent Development Table 133. Centrient Pharmaceuticals Company Information Table 134. Centrient Pharmaceuticals Business Overview Table 135. Centrient Pharmaceuticals Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio Table 137. Centrient Pharmaceuticals Recent Development Table 138. XINXIANG BEST PHARMACEUTICAL Company Information Table 139. XINXIANG BEST PHARMACEUTICAL Business Overview Table 140. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio Table 142. XINXIANG BEST PHARMACEUTICAL Recent Development Table 143. United Laboratories Company Information Table 144. United Laboratories Business Overview Table 145. United Laboratories Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. United Laboratories Penicillin Intermediate Product Portfolio Table 147. United Laboratories Recent Development Table 148. TUL Company Information Table 149. TUL Business Overview Table 150. TUL Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. TUL Penicillin Intermediate Product Portfolio Table 152. TUL Recent Development Table 153. Sinopharm Weiqida Pharmaceutical Company Information Table 154. Sinopharm Weiqida Pharmaceutical Business Overview Table 155. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 157. Sinopharm Weiqida Pharmaceutical Recent Development Table 158. Sichuan Huaxin Company Information Table 159. Sichuan Huaxin Business Overview Table 160. Sichuan Huaxin Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Sichuan Huaxin Penicillin Intermediate Product Portfolio Table 162. Sichuan Huaxin Recent Development Table 163. Qilu Tianhe Pharma Company Information Table 164. Qilu Tianhe Pharma Business Overview Table 165. Qilu Tianhe Pharma Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio Table 167. Qilu Tianhe Pharma Recent Development Table 168. Novartis Sandoz Anti-Infectives Company Information Table 169. Novartis Sandoz Anti-Infectives Business Overview Table 170. Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio Table 172. Novartis Sandoz Anti-Infectives Recent Development Table 173. LKPC Company Information Table 174. LKPC Business Overview Table 175. LKPC Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. LKPC Penicillin Intermediate Product Portfolio Table 177. LKPC Recent Development Table 178. Kelun Company Information Table 179. Kelun Business Overview Table 180. Kelun Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Kelun Penicillin Intermediate Product Portfolio Table 182. Kelun Recent Development Table 183. Jiangxi Fushine Pharmaceutical Company Information Table 184. Jiangxi Fushine Pharmaceutical Business Overview Table 185. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 186. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio Table 187. Jiangxi Fushine Pharmaceutical Recent Development Table 188. Huayao Group Company Information Table 189. Huayao Group Business Overview Table 190. Huayao Group Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 191. Huayao Group Penicillin Intermediate Product Portfolio Table 192. Huayao Group Recent Development Table 193. Hayao Company Information Table 194. Hayao Business Overview Table 195. Hayao Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 196. Hayao Penicillin Intermediate Product Portfolio Table 197. Hayao Recent Development Table 198. E-Cspc Company Information Table 199. E-Cspc Business Overview Table 200. E-Cspc Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 201. E-Cspc Penicillin Intermediate Product Portfolio Table 202. E-Cspc Recent Development Table 203. CSPC Zhongrun Company Information Table 204. CSPC Zhongrun Business Overview Table 205. CSPC Zhongrun Penicillin Intermediate Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 206. CSPC Zhongrun Penicillin Intermediate Product Portfolio Table 207. CSPC Zhongrun Recent Development Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Penicillin Intermediate Distributors List Table 211. Penicillin Intermediate Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Penicillin Intermediate Product Image Figure 2. Global Penicillin Intermediate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin Intermediate Market Size (2021-2032) & (US$ Million) Figure 4. Global Penicillin Intermediate Sales (2021-2032) & (Tons) Figure 5. Global Penicillin Intermediate Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Penicillin Intermediate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 6-APA Image Figure 9. Penicillin G and V Potassium Salt Image Figure 10. Others Image Figure 11. Global Penicillin Intermediate Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Penicillin Intermediate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Penicillin Intermediate Sales Market Share by Type (2021-2032) Figure 14. Global Penicillin Intermediate Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Penicillin Intermediate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Penicillin Intermediate Revenue Market Share by Type (2021-2032) Figure 17. Penicillin Antibiotics Image Figure 18. Cephalosporin Antibiotics Image Figure 19. Global Penicillin Intermediate Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Penicillin Intermediate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Penicillin Intermediate Sales Market Share by Application (2021-2032) Figure 22. Global Penicillin Intermediate Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Penicillin Intermediate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Penicillin Intermediate Revenue Market Share by Application (2021-2032) Figure 25. North America Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Penicillin Intermediate Sales Market Share by Country (2021-2032) Figure 27. U.S. Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Penicillin Intermediate Sales Market Share by Country (2021-2032) Figure 32. Germany Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Penicillin Intermediate Sales Market Share by Country (2021-2032) Figure 39. China Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Penicillin Intermediate Sales Market Share by Country (2021-2032) Figure 47. Brazil Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Penicillin Intermediate Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Penicillin Intermediate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Penicillin Intermediate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Figure 58. North America Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Penicillin Intermediate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Penicillin Intermediate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 6-APA
  • Penicillin G and V Potassium Salt
  • Others
Applications
  • Penicillin Antibiotics
  • Cephalosporin Antibiotics
Companies covered
  • Sinopharm Weiqida Pharmaceutical
  • Kasugamycin hydrochloride
  • Shanghai Hongsheng
  • Apeloa Pharmaceutical
  • The United Laboratories International Holdings Limited
  • Sichuan Kelun Pharmaceutical
  • Jiangxi Huabang
  • North China Pharmaceutical Company
  • Henan Huaxing
  • Harbin Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Fuan Pharmaceutical group
  • Yili Chuanning Biotechnology
  • Changzhou RedSun
  • Centrient Pharmaceuticals
  • XINXIANG BEST PHARMACEUTICAL
  • United Laboratories
  • TUL
  • Sinopharm Weiqida Pharmaceutical
  • Sichuan Huaxin
  • Qilu Tianhe Pharma
  • Novartis Sandoz Anti-Infectives
  • LKPC
  • Kelun
  • Jiangxi Fushine Pharmaceutical
  • Huayao Group
  • Hayao
  • E-Cspc
  • CSPC Zhongrun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Penicillin Intermediate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Penicillin Intermediate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Penicillin Intermediate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Penicillin Intermediate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Penicillin Intermediate Market Dynamics
  1. 2.1 Penicillin Intermediate Industry Trends
  2. 2.2 Penicillin Intermediate Industry Drivers
  3. 2.3 Penicillin Intermediate Industry Opportunities and Challenges
  4. 2.4 Penicillin Intermediate Industry Restraints
3 Penicillin Intermediate Market by Manufacturers
  1. 3.1 Global Penicillin Intermediate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Penicillin Intermediate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Penicillin Intermediate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Penicillin Intermediate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Penicillin Intermediate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Penicillin Intermediate Manufacturers, Product Type & Application
  7. 3.7 Global Penicillin Intermediate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Penicillin Intermediate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Penicillin Intermediate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Penicillin Intermediate Tier 1, Tier 2, and Tier 3
4 Penicillin Intermediate Market by Type
  1. 4.1 Penicillin Intermediate Type Introduction
  2. 4.1.1 6-APA
  3. 4.1.2 Penicillin G and V Potassium Salt
  4. 4.1.3 Others
  5. 4.2 Global Penicillin Intermediate Sales by Type
  6. 4.2.1 Global Penicillin Intermediate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Penicillin Intermediate Sales by Type (2021-2032)
  8. 4.2.3 Global Penicillin Intermediate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Penicillin Intermediate Revenue by Type
  10. 4.3.1 Global Penicillin Intermediate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Penicillin Intermediate Revenue by Type (2021-2032)
  12. 4.3.3 Global Penicillin Intermediate Revenue Market Share by Type (2021-2032)
5 Penicillin Intermediate Market by Application
  1. 5.1 Penicillin Intermediate Application Introduction
  2. 5.1.1 Penicillin Antibiotics
  3. 5.1.2 Cephalosporin Antibiotics
  4. 5.2 Global Penicillin Intermediate Sales by Application
  5. 5.2.1 Global Penicillin Intermediate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Penicillin Intermediate Sales by Application (2021-2032)
  7. 5.2.3 Global Penicillin Intermediate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Penicillin Intermediate Revenue by Application
  9. 5.3.1 Global Penicillin Intermediate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Penicillin Intermediate Revenue by Application (2021-2032)
  11. 5.3.3 Global Penicillin Intermediate Revenue Market Share by Application (2021-2032)
6 Global Penicillin Intermediate Sales by Region
  1. 6.1 Global Penicillin Intermediate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Penicillin Intermediate Sales by Region (2021-2032)
  3. 6.2.1 Global Penicillin Intermediate Sales by Region (2021-2026)
  4. 6.2.2 Global Penicillin Intermediate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Penicillin Intermediate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Penicillin Intermediate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Penicillin Intermediate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Penicillin Intermediate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Penicillin Intermediate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Penicillin Intermediate Revenue by Region
  1. 7.1 Global Penicillin Intermediate Revenue by Region
  2. 7.1.1 Global Penicillin Intermediate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Penicillin Intermediate Revenue by Region (2021-2026)
  4. 7.1.3 Global Penicillin Intermediate Revenue by Region (2027-2032)
  5. 7.1.4 Global Penicillin Intermediate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Penicillin Intermediate Revenue (2021-2032)
  8. 7.2.2 North America Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Penicillin Intermediate Revenue (2021-2032)
  11. 7.3.2 Europe Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Penicillin Intermediate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Penicillin Intermediate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Penicillin Intermediate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sinopharm Weiqida Pharmaceutical
  2. 8.1.1 Sinopharm Weiqida Pharmaceutical Company Information
  3. 8.1.2 Sinopharm Weiqida Pharmaceutical Business Overview
  4. 8.1.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  6. 8.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  7. 8.2 Kasugamycin hydrochloride
  8. 8.2.1 Kasugamycin hydrochloride Company Information
  9. 8.2.2 Kasugamycin hydrochloride Business Overview
  10. 8.2.3 Kasugamycin hydrochloride Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio
  12. 8.2.5 Kasugamycin hydrochloride Recent Developments
  13. 8.3 Shanghai Hongsheng
  14. 8.3.1 Shanghai Hongsheng Company Information
  15. 8.3.2 Shanghai Hongsheng Business Overview
  16. 8.3.3 Shanghai Hongsheng Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Hongsheng Penicillin Intermediate Product Portfolio
  18. 8.3.5 Shanghai Hongsheng Recent Developments
  19. 8.4 Apeloa Pharmaceutical
  20. 8.4.1 Apeloa Pharmaceutical Company Information
  21. 8.4.2 Apeloa Pharmaceutical Business Overview
  22. 8.4.3 Apeloa Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio
  24. 8.4.5 Apeloa Pharmaceutical Recent Developments
  25. 8.5 The United Laboratories International Holdings Limited
  26. 8.5.1 The United Laboratories International Holdings Limited Company Information
  27. 8.5.2 The United Laboratories International Holdings Limited Business Overview
  28. 8.5.3 The United Laboratories International Holdings Limited Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio
  30. 8.5.5 The United Laboratories International Holdings Limited Recent Developments
  31. 8.6 Sichuan Kelun Pharmaceutical
  32. 8.6.1 Sichuan Kelun Pharmaceutical Company Information
  33. 8.6.2 Sichuan Kelun Pharmaceutical Business Overview
  34. 8.6.3 Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio
  36. 8.6.5 Sichuan Kelun Pharmaceutical Recent Developments
  37. 8.7 Jiangxi Huabang
  38. 8.7.1 Jiangxi Huabang Company Information
  39. 8.7.2 Jiangxi Huabang Business Overview
  40. 8.7.3 Jiangxi Huabang Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Huabang Penicillin Intermediate Product Portfolio
  42. 8.7.5 Jiangxi Huabang Recent Developments
  43. 8.8 North China Pharmaceutical Company
  44. 8.8.1 North China Pharmaceutical Company Company Information
  45. 8.8.2 North China Pharmaceutical Company Business Overview
  46. 8.8.3 North China Pharmaceutical Company Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 North China Pharmaceutical Company Penicillin Intermediate Product Portfolio
  48. 8.8.5 North China Pharmaceutical Company Recent Developments
  49. 8.9 Henan Huaxing
  50. 8.9.1 Henan Huaxing Company Information
  51. 8.9.2 Henan Huaxing Business Overview
  52. 8.9.3 Henan Huaxing Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Henan Huaxing Penicillin Intermediate Product Portfolio
  54. 8.9.5 Henan Huaxing Recent Developments
  55. 8.10 Harbin Pharmaceutical Group
  56. 8.10.1 Harbin Pharmaceutical Group Company Information
  57. 8.10.2 Harbin Pharmaceutical Group Business Overview
  58. 8.10.3 Harbin Pharmaceutical Group Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio
  60. 8.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 8.11 Shanghai Shyndec Pharmaceutical
  62. 8.11.1 Shanghai Shyndec Pharmaceutical Company Information
  63. 8.11.2 Shanghai Shyndec Pharmaceutical Business Overview
  64. 8.11.3 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio
  66. 8.11.5 Shanghai Shyndec Pharmaceutical Recent Developments
  67. 8.12 Fuan Pharmaceutical group
  68. 8.12.1 Fuan Pharmaceutical group Company Information
  69. 8.12.2 Fuan Pharmaceutical group Business Overview
  70. 8.12.3 Fuan Pharmaceutical group Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio
  72. 8.12.5 Fuan Pharmaceutical group Recent Developments
  73. 8.13 Yili Chuanning Biotechnology
  74. 8.13.1 Yili Chuanning Biotechnology Company Information
  75. 8.13.2 Yili Chuanning Biotechnology Business Overview
  76. 8.13.3 Yili Chuanning Biotechnology Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio
  78. 8.13.5 Yili Chuanning Biotechnology Recent Developments
  79. 8.14 Changzhou RedSun
  80. 8.14.1 Changzhou RedSun Company Information
  81. 8.14.2 Changzhou RedSun Business Overview
  82. 8.14.3 Changzhou RedSun Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Changzhou RedSun Penicillin Intermediate Product Portfolio
  84. 8.14.5 Changzhou RedSun Recent Developments
  85. 8.15 Centrient Pharmaceuticals
  86. 8.15.1 Centrient Pharmaceuticals Company Information
  87. 8.15.2 Centrient Pharmaceuticals Business Overview
  88. 8.15.3 Centrient Pharmaceuticals Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio
  90. 8.15.5 Centrient Pharmaceuticals Recent Developments
  91. 8.16 XINXIANG BEST PHARMACEUTICAL
  92. 8.16.1 XINXIANG BEST PHARMACEUTICAL Company Information
  93. 8.16.2 XINXIANG BEST PHARMACEUTICAL Business Overview
  94. 8.16.3 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio
  96. 8.16.5 XINXIANG BEST PHARMACEUTICAL Recent Developments
  97. 8.17 United Laboratories
  98. 8.17.1 United Laboratories Company Information
  99. 8.17.2 United Laboratories Business Overview
  100. 8.17.3 United Laboratories Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 United Laboratories Penicillin Intermediate Product Portfolio
  102. 8.17.5 United Laboratories Recent Developments
  103. 8.18 TUL
  104. 8.18.1 TUL Company Information
  105. 8.18.2 TUL Business Overview
  106. 8.18.3 TUL Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 TUL Penicillin Intermediate Product Portfolio
  108. 8.18.5 TUL Recent Developments
  109. 8.19 Sinopharm Weiqida Pharmaceutical
  110. 8.19.1 Sinopharm Weiqida Pharmaceutical Company Information
  111. 8.19.2 Sinopharm Weiqida Pharmaceutical Business Overview
  112. 8.19.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  114. 8.19.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  115. 8.20 Sichuan Huaxin
  116. 8.20.1 Sichuan Huaxin Company Information
  117. 8.20.2 Sichuan Huaxin Business Overview
  118. 8.20.3 Sichuan Huaxin Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sichuan Huaxin Penicillin Intermediate Product Portfolio
  120. 8.20.5 Sichuan Huaxin Recent Developments
  121. 8.21 Qilu Tianhe Pharma
  122. 8.21.1 Qilu Tianhe Pharma Company Information
  123. 8.21.2 Qilu Tianhe Pharma Business Overview
  124. 8.21.3 Qilu Tianhe Pharma Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio
  126. 8.21.5 Qilu Tianhe Pharma Recent Developments
  127. 8.22 Novartis Sandoz Anti-Infectives
  128. 8.22.1 Novartis Sandoz Anti-Infectives Company Information
  129. 8.22.2 Novartis Sandoz Anti-Infectives Business Overview
  130. 8.22.3 Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio
  132. 8.22.5 Novartis Sandoz Anti-Infectives Recent Developments
  133. 8.23 LKPC
  134. 8.23.1 LKPC Company Information
  135. 8.23.2 LKPC Business Overview
  136. 8.23.3 LKPC Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 LKPC Penicillin Intermediate Product Portfolio
  138. 8.23.5 LKPC Recent Developments
  139. 8.24 Kelun
  140. 8.24.1 Kelun Company Information
  141. 8.24.2 Kelun Business Overview
  142. 8.24.3 Kelun Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Kelun Penicillin Intermediate Product Portfolio
  144. 8.24.5 Kelun Recent Developments
  145. 8.25 Jiangxi Fushine Pharmaceutical
  146. 8.25.1 Jiangxi Fushine Pharmaceutical Company Information
  147. 8.25.2 Jiangxi Fushine Pharmaceutical Business Overview
  148. 8.25.3 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio
  150. 8.25.5 Jiangxi Fushine Pharmaceutical Recent Developments
  151. 8.26 Huayao Group
  152. 8.26.1 Huayao Group Company Information
  153. 8.26.2 Huayao Group Business Overview
  154. 8.26.3 Huayao Group Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Huayao Group Penicillin Intermediate Product Portfolio
  156. 8.26.5 Huayao Group Recent Developments
  157. 8.27 Hayao
  158. 8.27.1 Hayao Company Information
  159. 8.27.2 Hayao Business Overview
  160. 8.27.3 Hayao Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Hayao Penicillin Intermediate Product Portfolio
  162. 8.27.5 Hayao Recent Developments
  163. 8.28 E-Cspc
  164. 8.28.1 E-Cspc Company Information
  165. 8.28.2 E-Cspc Business Overview
  166. 8.28.3 E-Cspc Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 E-Cspc Penicillin Intermediate Product Portfolio
  168. 8.28.5 E-Cspc Recent Developments
  169. 8.29 CSPC Zhongrun
  170. 8.29.1 CSPC Zhongrun Company Information
  171. 8.29.2 CSPC Zhongrun Business Overview
  172. 8.29.3 CSPC Zhongrun Penicillin Intermediate Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 CSPC Zhongrun Penicillin Intermediate Product Portfolio
  174. 8.29.5 CSPC Zhongrun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Penicillin Intermediate Value Chain Analysis
  2. 9.1.1 Penicillin Intermediate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Penicillin Intermediate Production Mode & Process
  6. 9.2 Penicillin Intermediate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Penicillin Intermediate Distributors
  9. 9.2.3 Penicillin Intermediate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst